Skip to search formSkip to main contentSkip to account menu

NSC-526417

Known as: NSC 526417, NSC526417 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Echinomycin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Activity of two phase I drugs N-methylformamide (NSC-3051) and Echinomycin (NSC-526417) against fresh surgical explants of human tumors in the 6-day subrenal capsule (SRC) assay
SummaryThe potential clinical activity of the new phase I drugs N-methylformamide (N-MF) and Echinomycin (ECH) was examined while… 
1993
1993
Phase II evaluation of echinomycin (NSC-526417) in patients with central nervous system malignancies
SummaryThe objective of this trial was to determine the efficacy of echinomycin (1.2mg/m2) administered on a weekly times four… 
1990
1990
A phase II trial of echinomycin in metastatic cervix carcinoma
We conclude echinomycin is not active in metastatic cervix cancer in the dose and schedule studied 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)